Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
Stålhammar NO, Carlsson J, Peacock R, Müller-Lissner S, Bigard MA, Porro GB, Ponce J, Hosie J, Scott M, Weir DG, Fulton C, Gillon K, Bardhan KD.
Stålhammar NO, et al. Among authors: weir dg.
Pharmacoeconomics. 1999 Nov;16(5 Pt 1):483-97. doi: 10.2165/00019053-199916050-00006.
Pharmacoeconomics. 1999.
PMID: 10662395
Clinical Trial.
CONCLUSIONS: Following a pragmatic interpretation, incorporating intermediate short term results, the results in this study give no support to the notion that a step-up approach, either as dose titration from omeprazole 10 mg to omeprazole 20 mg or as drug switching from r …
CONCLUSIONS: Following a pragmatic interpretation, incorporating intermediate short term results, the results in this study give no s …